Spleen tyrosine kinase activity regulates epidermal growth factor receptor signaling pathway in ovarian cancer

Medicine and Dentistry

• Epidermal Growth Factor Receptor 100%
• Ovarian Cancer 100%
• Protein Kinase Syk 100%
• Signal Transduction 100%
• Cancer Research 9%
• Malignant Neoplasm 9%
• Cancer Tissue 9%
• Phosphotransferase 9%
• Overall Survival 9%
• Immunoreactivity 9%
• Immunohistochemistry 9%
• Medicine 9%
• Kaplan Meier Method 9%
• Log Rank Test 9%
• Obstetrics 9%
• Gynecology 9%
• Tumor Xenograft 9%
• Mass Spectrum 9%
• Krukenberg Tumor 9%
• Protein Kinase Syk Inhibitor 9%
• Serous Carcinoma 9%
• RNA Sequencing 9%
• Paclitaxel 9%
• Transcriptome 9%
• Immunoblotting 9%
• Lapatinib 9%

Biochemistry, Genetics and Molecular Biology

• Signal Transduction 100%
• Epidermal Growth Factor Receptor 100%
• Janus Kinase 1 100%
• Western Blot 8%
• Small Molecule 8%
• Overall Survival 8%
• Immunoreactivity 8%
• Transcription 8%
• Mass Spectrometry 8%
• Tyrosine Kinase Inhibitor 8%
• Syngenic 8%
• RNA Sequencing 8%
• Phosphoproteomics 8%
• Lapatinib 8%
• Kinase 8%
• Phosphotransferase 8%
• Transcriptome 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Protein Kinase Syk 100%
• Ovary Cancer 100%
• Epidermal Growth Factor Receptor 100%
• Paclitaxel 9%
• Malignant Neoplasm 9%
• Western Blot 9%
• Phosphotransferase 9%
• Overall Survival 9%
• Lapatinib 9%
• Ovary Carcinoma 9%
• Protein Kinase Syk Inhibitor 9%
• Neoplasm 9%
• Carcinoma 9%
• Transcriptome 9%